ADMA Biologics Inc Total Non-Operating Income/Expense 2013-2025 | ADMA
ADMA Biologics Inc total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.011B, a 76.16% decline year-over-year.
- ADMA Biologics Inc annual total non-operating income/expense for 2024 was $-0.013B, a 73.39% decline from 2023.
- ADMA Biologics Inc annual total non-operating income/expense for 2023 was $-0.05B, a 87.92% increase from 2022.
- ADMA Biologics Inc annual total non-operating income/expense for 2022 was $-0.027B, a 99.93% increase from 2021.